ANNABELLE LAYUGAN: Open Payments
NPI 1457611204 · SECAUCUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$378 in 4 payments from 3 companies in 2025. Trend: 2023 $120 · 2024 $138 · 2025 $378
Food & beverage: $378
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $241 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $12 |
Products named: AREXVY, Ozempic, Wegovy, LifeVest.
Industry payments across NJ — which companies pay providers there.
